,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,characteristics_ch1.7,characteristics_ch1.8,characteristics_ch1.9,treatment_protocol_ch1,growth_protocol_ch1,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,data_processing,platform_id,contact_name,contact_email,contact_institute,contact_address,contact_city,contact_zip/postal_code,contact_country,supplementary_file,data_row_count,adjuvant treatment:ch1,age:ch1,days to determined death status:ch1,days to recurrence / to last visit:ch1,dead:ch1,gender:ch1,histology:ch1,performance status corresponding to who criteria:ch1,recurrence:ch1,tumor stage:ch1
GSM1019139,"Patient 11, female, adeno",GSM1019139,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 11,Homo sapiens,dead: no,days to determined death status: 3186,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 66,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 3223,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 11,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019139/suppl/GSM1019139_PA025_human_11C_070509.CEL.gz,54675,no,66,3186,3223,no,female,adeno,1,yes,1a
GSM1019140,"Patient 12, male, adeno",GSM1019140,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 12,Homo sapiens,dead: yes,days to determined death status: 162,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 77,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 154,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 12,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019140/suppl/GSM1019140_PA025_human_12B_070912.CEL.gz,54675,no,77,162,154,yes,male,adeno,1,yes,1a
GSM1019143,"Patient 19, female, adeno",GSM1019143,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 19,Homo sapiens,dead: yes,days to determined death status: 556,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 40,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 470,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 19,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019143/suppl/GSM1019143_PA025_19A_081028_HG-U133_Plus_2_.CEL.gz,54675,yes,40,556,470,yes,female,adeno,1,yes,1b
GSM1019144,"Patient 22, male, adeno",GSM1019144,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 22,Homo sapiens,dead: yes,days to determined death status: 304,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 68,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 91,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 22,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019144/suppl/GSM1019144_PA025_22B_081028_HG-U133_Plus_2_.CEL.gz,54675,no,68,304,91,yes,male,adeno,0,yes,3a
GSM1019145,"Patient 23, female, adeno",GSM1019145,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 23,Homo sapiens,dead: yes,days to determined death status: 590,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 65,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 222,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 23,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019145/suppl/GSM1019145_PA025_23A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,65,590,222,yes,female,adeno,1,no,1b
GSM1019147,"Patient 32, male, adeno",GSM1019147,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 32,Homo sapiens,dead: yes,days to determined death status: 61,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 78,gender: male,adjuvant treatment: no,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 32,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019147/suppl/GSM1019147_PA025_human_32A_070509.CEL.gz,54675,no,78,61,not known,yes,male,adeno,1,not known,1b
GSM1019149,"Patient 35, female, adeno",GSM1019149,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 35,Homo sapiens,dead: yes,days to determined death status: 595,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 74,gender: female,adjuvant treatment: no,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 35,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019149/suppl/GSM1019149_PA025_human_35A_070912.CEL.gz,54675,no,74,595,not known,yes,female,adeno,1,not known,1b
GSM1019150,"Patient 37, female, adeno",GSM1019150,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 37,Homo sapiens,dead: yes,days to determined death status: 1839,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 71,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 37,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019150/suppl/GSM1019150_PA025_human_37A_070228.CEL.gz,54675,not known,71,1839,not known,yes,female,adeno,0,not known,1a
GSM1019152,"Patient 48, female, adeno",GSM1019152,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 48,Homo sapiens,dead: yes,days to determined death status: 523,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 54,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 48,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019152/suppl/GSM1019152_PA025_human_48A_070509.CEL.gz,54675,not known,54,523,not known,yes,female,adeno,0,not known,1b
GSM1019153,"Patient 61, male, adeno",GSM1019153,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 61,Homo sapiens,dead: yes,days to determined death status: 393,histology: adeno,tumor stage: 3b,performance status corresponding to who criteria: 0,age: 73,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 61,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019153/suppl/GSM1019153_PA025_61A_081029_HG-U133_Plus_2_.CEL.gz,54675,not known,73,393,not known,yes,male,adeno,0,not known,3b
GSM1019154,"Patient 81, male, adeno",GSM1019154,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 81,Homo sapiens,dead: yes,days to determined death status: 250,histology: adeno,tumor stage: 4,performance status corresponding to who criteria: 0,age: 56,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 81,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019154/suppl/GSM1019154_PA025_human_81A_070509.CEL.gz,54675,not known,56,250,not known,yes,male,adeno,0,not known,4
GSM1019158,"Patient 112, male, adeno",GSM1019158,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 112,Homo sapiens,dead: yes,days to determined death status: 490,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 70,gender: male,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 437,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 112,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019158/suppl/GSM1019158_PA025_human_112B_070912.CEL.gz,54675,yes,70,490,437,yes,male,adeno,0,yes,1b
GSM1019160,"Patient 133, female, adeno",GSM1019160,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 133,Homo sapiens,dead: yes,days to determined death status: 84,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 72,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 83,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 133,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019160/suppl/GSM1019160_PA025_133A_081106_HG-U133_Plus_2_.CEL.gz,54675,no,72,84,83,yes,female,adeno,0,no,1b
GSM1019162,"Patient 162, male, adeno",GSM1019162,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 162,Homo sapiens,dead: yes,days to determined death status: 355,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 70,gender: male,adjuvant treatment: yes,recurrence: no,days to recurrence / to last visit: 359,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 162,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019162/suppl/GSM1019162_PA025_human_162A_070509.CEL.gz,54675,yes,70,355,359,yes,male,adeno,0,no,1b
GSM1019163,"Patient 165, male, adeno",GSM1019163,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 165,Homo sapiens,dead: yes,days to determined death status: 88,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 74,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 165,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019163/suppl/GSM1019163_PA025_human_165C_070509.CEL.gz,54675,not known,74,88,not known,yes,male,adeno,0,not known,2b
GSM1019164,"Patient 169, female, adeno",GSM1019164,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 169,Homo sapiens,dead: yes,days to determined death status: 286,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 2,age: 54,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 239,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 169,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019164/suppl/GSM1019164_PA025_human_169D_070228.CEL.gz,54675,no,54,286,239,yes,female,adeno,2,yes,3a
GSM1019165,"Patient 171, male, adeno",GSM1019165,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 171,Homo sapiens,dead: yes,days to determined death status: 151,histology: adeno,tumor stage: 2a,performance status corresponding to who criteria: 1,age: 71,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 54,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 171,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019165/suppl/GSM1019165_PA025_171A_081211_HG-U133_Plus_2_.CEL.gz,54675,no,71,151,54,yes,male,adeno,1,no,2a
GSM1019166,"Patient 172, female, adeno",GSM1019166,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 172,Homo sapiens,dead: yes,days to determined death status: 2108,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 70,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 1119,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 172,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019166/suppl/GSM1019166_PA025_human_172C_070912.CEL.gz,54675,no,70,2108,1119,yes,female,adeno,1,yes,1b
GSM1019169,"Patient 189, female, adeno",GSM1019169,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 189,Homo sapiens,dead: yes,days to determined death status: 3470,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 75,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 3383,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 189,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019169/suppl/GSM1019169_PA025_human_189A_070509.CEL.gz,54675,no,75,3470,3383,yes,female,adeno,0,no,3a
GSM1019170,"Patient 192, male, adeno",GSM1019170,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 192,Homo sapiens,dead: yes,days to determined death status: 4030,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 69,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 4041,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 192,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019170/suppl/GSM1019170_PA025_192C_081106_HG-U133_Plus_2_.CEL.gz,54675,no,69,4030,4041,yes,male,adeno,0,no,1b
GSM1019171,"Patient 193, female, adeno",GSM1019171,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 193,Homo sapiens,dead: yes,days to determined death status: 3260,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 62,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2531,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 193,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019171/suppl/GSM1019171_PA025_193B_081106_HG-U133_Plus_2_.CEL.gz,54675,no,62,3260,2531,yes,female,adeno,0,no,1a
GSM1019174,"Patient 197, male, adeno",GSM1019174,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 197,Homo sapiens,dead: yes,days to determined death status: 514,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 1,age: 66,gender: male,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 503,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 197,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019174/suppl/GSM1019174_PA025_human_197B_070509.CEL.gz,54675,yes,66,514,503,yes,male,adeno,1,yes,2b
GSM1019175,"Patient 200, male, adeno",GSM1019175,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 200,Homo sapiens,dead: no,days to determined death status: 5712,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 56,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2954,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 200,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019175/suppl/GSM1019175_PA025_200A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,56,5712,2954,no,male,adeno,0,no,1a
GSM1019176,"Patient 201, female, adeno",GSM1019176,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 201,Homo sapiens,dead: yes,days to determined death status: 281,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 76,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 247,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 201,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019176/suppl/GSM1019176_PA025_201A_090109_HG-U133_Plus_2_.CEL.gz,54675,no,76,281,247,yes,female,adeno,1,yes,1b
GSM1019180,"Patient 212, male, adeno",GSM1019180,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 212,Homo sapiens,dead: yes,days to determined death status: 343,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 66,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 116,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 212,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019180/suppl/GSM1019180_PA025_212A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,66,343,116,yes,male,adeno,0,yes,1b
GSM1019181,"Patient 213, female, adeno",GSM1019181,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 213,Homo sapiens,dead: yes,days to determined death status: 3221,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 52,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 2579,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 213,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019181/suppl/GSM1019181_PA025_213A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,52,3221,2579,yes,female,adeno,0,yes,1a
GSM1019183,"Patient 215, female, adeno",GSM1019183,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 215,Homo sapiens,dead: yes,days to determined death status: 591,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 51,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 190,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 215,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019183/suppl/GSM1019183_PA025_215A_090128_HG-U133_Plus_2_.CEL.gz,54675,no,51,591,190,yes,female,adeno,0,yes,1b
GSM1019185,"Patient 223, male, adeno",GSM1019185,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 223,Homo sapiens,dead: yes,days to determined death status: 3719,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 62,gender: male,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 2905,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 223,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019185/suppl/GSM1019185_PA025_223A_081028_HG-U133_Plus_2_.CEL.gz,54675,yes,62,3719,2905,yes,male,adeno,0,yes,2b
GSM1019186,"Patient 224, female, adeno",GSM1019186,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 224,Homo sapiens,dead: no,days to determined death status: 3844,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 1,age: 64,gender: female,adjuvant treatment: yes,recurrence: no,days to recurrence / to last visit: 2086,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 224,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019186/suppl/GSM1019186_PA025_224A_081028_HG-U133_Plus_2_.CEL.gz,54675,yes,64,3844,2086,no,female,adeno,1,no,2b
GSM1019187,"Patient 228, female, adeno",GSM1019187,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 228,Homo sapiens,dead: yes,days to determined death status: 3331,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 82,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 1707,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 228,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019187/suppl/GSM1019187_PA025_228B_081028_HG-U133_Plus_2_.CEL.gz,54675,no,82,3331,1707,yes,female,adeno,0,yes,1b
GSM1019188,"Patient 229, female, adeno",GSM1019188,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 229,Homo sapiens,dead: no,days to determined death status: 3723,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 55,gender: female,adjuvant treatment: yes,recurrence: no,days to recurrence / to last visit: 966,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 229,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019188/suppl/GSM1019188_PA025_human_229A_070912.CEL.gz,54675,yes,55,3723,966,no,female,adeno,0,no,1b
GSM1019190,"Patient 235, female, adeno",GSM1019190,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 235,Homo sapiens,dead: no,days to determined death status: 3621,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 71,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 1728,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 235,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019190/suppl/GSM1019190_PA025_human_235A_070912.CEL.gz,54675,no,71,3621,1728,no,female,adeno,0,no,1b
GSM1019192,"Patient 247, female, adeno",GSM1019192,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 247,Homo sapiens,dead: no,days to determined death status: 3369,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 75,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 1726,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 247,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019192/suppl/GSM1019192_PA025_human_247A_070926.CEL.gz,54675,no,75,3369,1726,no,female,adeno,1,no,1a
GSM1019194,"Patient 255, female, adeno",GSM1019194,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 255,Homo sapiens,dead: yes,days to determined death status: 2844,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 74,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2883,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 255,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019194/suppl/GSM1019194_PA025_human_255A_070926.CEL.gz,54675,no,74,2844,2883,yes,female,adeno,0,no,3a
GSM1019196,"Patient 258, male, adeno",GSM1019196,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 258,Homo sapiens,dead: yes,days to determined death status: 6,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 1,age: 59,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 6,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 258,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019196/suppl/GSM1019196_PA025_human_258A_071005.CEL.gz,54675,no,59,6,6,yes,male,adeno,1,no,3a
GSM1019197,"Patient 260, male, adeno",GSM1019197,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 260,Homo sapiens,dead: yes,days to determined death status: 196,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 2,age: 59,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 133,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 260,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019197/suppl/GSM1019197_PA025_260A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,59,196,133,yes,male,adeno,2,yes,1b
GSM1019200,"Patient 272, female, adeno",GSM1019200,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 272,Homo sapiens,dead: yes,days to determined death status: 351,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 51,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 272,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019200/suppl/GSM1019200_PA025_272B_081029_HG-U133_Plus_2_.CEL.gz,54675,not known,51,351,not known,yes,female,adeno,0,not known,2b
GSM1019203,"Patient 282, female, adeno",GSM1019203,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 282,Homo sapiens,dead: yes,days to determined death status: 79,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 1,age: 70,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 282,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019203/suppl/GSM1019203_PA025_282A_081029_HG-U133_Plus_2_.CEL.gz,54675,not known,70,79,not known,yes,female,adeno,1,not known,2b
GSM1019204,"Patient 284, male, adeno",GSM1019204,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 284,Homo sapiens,dead: yes,days to determined death status: 3949,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 70,gender: male,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 2380,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 284,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019204/suppl/GSM1019204_PA025_human_284A_070912.CEL.gz,54675,yes,70,3949,2380,yes,male,adeno,0,yes,2b
GSM1019205,"Patient 288, male, adeno",GSM1019205,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 288,Homo sapiens,dead: no,days to determined death status: 4703,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 59,gender: male,adjuvant treatment: yes,recurrence: no,days to recurrence / to last visit: 4978,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 288,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019205/suppl/GSM1019205_PA025_human_288A_070914.CEL.gz,54675,yes,59,4703,4978,no,male,adeno,0,no,1a
GSM1019207,"Patient 292, female, adeno",GSM1019207,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 292,Homo sapiens,dead: yes,days to determined death status: 247,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 57,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 292,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019207/suppl/GSM1019207_PA025_292B_081029_HG-U133_Plus_2_.CEL.gz,54675,not known,57,247,not known,yes,female,adeno,0,not known,1b
GSM1019210,"Patient 297, male, adeno",GSM1019210,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 297,Homo sapiens,dead: yes,days to determined death status: 2748,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 66,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2750,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 297,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019210/suppl/GSM1019210_PA025_human_297A_070912.CEL.gz,54675,no,66,2748,2750,yes,male,adeno,0,no,1a
GSM1019211,"Patient 299, female, adeno",GSM1019211,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 299,Homo sapiens,dead: yes,days to determined death status: 323,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 60,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 306,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 299,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019211/suppl/GSM1019211_PA025_human_299B_070912.CEL.gz,54675,yes,60,323,306,yes,female,adeno,0,yes,3a
GSM1019213,"Patient 301, male, adeno",GSM1019213,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 301,Homo sapiens,dead: no,days to determined death status: 4489,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 61,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 3760,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 301,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019213/suppl/GSM1019213_PA025_301A_081029_HG-U133_Plus_2_.CEL.gz,54675,no,61,4489,3760,no,male,adeno,0,yes,1b
GSM1019214,"Patient 302, female, adeno",GSM1019214,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 302,Homo sapiens,dead: no,days to determined death status: 4486,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 55,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2084,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 302,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019214/suppl/GSM1019214_PA025_302A_081106_HG-U133_Plus_2_.CEL.gz,54675,no,55,4486,2084,no,female,adeno,0,no,1a
GSM1019216,"Patient 309, female, adeno",GSM1019216,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 309,Homo sapiens,dead: yes,days to determined death status: 396,histology: adeno,tumor stage: 3b,performance status corresponding to who criteria: 0,age: 59,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 185,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 309,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019216/suppl/GSM1019216_PA025_human_309A_070921.CEL.gz,54675,yes,59,396,185,yes,female,adeno,0,yes,3b
GSM1019217,"Patient 310, female, adeno",GSM1019217,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 310,Homo sapiens,dead: yes,days to determined death status: 370,histology: adeno,tumor stage: 4,performance status corresponding to who criteria: 0,age: 70,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 212,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 310,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019217/suppl/GSM1019217_PA025_human_310A_070912.CEL.gz,54675,yes,70,370,212,yes,female,adeno,0,yes,4
GSM1019218,"Patient 311, male, adeno",GSM1019218,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 311,Homo sapiens,dead: yes,days to determined death status: 262,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 67,gender: male,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 179,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 311,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019218/suppl/GSM1019218_PA025_311C_081106_HG-U133_Plus_2_.CEL.gz,54675,no,67,262,179,yes,male,adeno,0,yes,1b
GSM1019220,"Patient 317, female, adeno",GSM1019220,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 317,Homo sapiens,dead: yes,days to determined death status: 533,histology: adeno,tumor stage: 2a,performance status corresponding to who criteria: 1,age: 64,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 138,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 317,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019220/suppl/GSM1019220_PA025_human_317A_070926.CEL.gz,54675,no,64,533,138,yes,female,adeno,1,yes,2a
GSM1019224,"Patient 338, female, adeno",GSM1019224,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 338,Homo sapiens,dead: yes,days to determined death status: 1874,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 49,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 255,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 338,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019224/suppl/GSM1019224_PA025_human_338A_071005.CEL.gz,54675,yes,49,1874,255,yes,female,adeno,0,yes,2b
GSM1019225,"Patient 341, female, adeno",GSM1019225,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 341,Homo sapiens,dead: yes,days to determined death status: 177,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 1,age: 51,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 7,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 341,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019225/suppl/GSM1019225_PA025_341A_081106_HG-U133_Plus_2_.CEL.gz,54675,no,51,177,7,yes,female,adeno,1,no,2b
GSM1019228,"Patient 347, male, adeno",GSM1019228,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 347,Homo sapiens,dead: no,days to determined death status: 5082,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 54,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 347,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019228/suppl/GSM1019228_PA025_human_347A_070907.CEL.gz,54675,not known,54,5082,not known,no,male,adeno,1,not known,1b
GSM1019230,"Patient 359, female, adeno",GSM1019230,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 359,Homo sapiens,dead: yes,days to determined death status: 2397,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 68,gender: female,adjuvant treatment: yes,recurrence: no,days to recurrence / to last visit: 2267,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 359,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019230/suppl/GSM1019230_PA025_human_359A_070907.CEL.gz,54675,yes,68,2397,2267,yes,female,adeno,0,no,3a
GSM1019234,"Patient 369, female, adeno",GSM1019234,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 369,Homo sapiens,dead: yes,days to determined death status: 2068,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 51,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 622,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 369,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019234/suppl/GSM1019234_PA025_369A_081028_HG-U133_Plus_2_.CEL.gz,54675,no,51,2068,622,yes,female,adeno,0,yes,1b
GSM1019236,"Patient 373, female, adeno",GSM1019236,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 373,Homo sapiens,dead: yes,days to determined death status: 3545,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 3,age: 47,gender: female,adjuvant treatment: yes,recurrence: yes,days to recurrence / to last visit: 3169,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 373,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019236/suppl/GSM1019236_PA025_human_373B_070907.CEL.gz,54675,yes,47,3545,3169,yes,female,adeno,3,yes,2b
GSM1019239,"Patient 7, male, adeno",GSM1019239,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 7,Homo sapiens,dead: yes,days to determined death status: 1222,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 55,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 7,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019239/suppl/GSM1019239_PA117_7A_101118_HG-U133_Plus_2_.CEL.gz,54675,not known,55,1222,not known,yes,male,adeno,1,not known,1b
GSM1019242,"Patient 16, female, adeno",GSM1019242,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 16,Homo sapiens,dead: no,days to determined death status: 3227,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 66,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2086,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 16,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019242/suppl/GSM1019242_PA117_16A_101118_HG-U133_Plus_2_.CEL.gz,54675,no,66,3227,2086,no,female,adeno,0,no,1b
GSM1019243,"Patient 20, male, adeno",GSM1019243,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 20,Homo sapiens,dead: yes,days to determined death status: 1031,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 60,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 20,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019243/suppl/GSM1019243_PA117_20A_101118_HG-U133_Plus_2_.CEL.gz,54675,not known,60,1031,not known,yes,male,adeno,0,not known,1b
GSM1019244,"Patient 28, female, adeno",GSM1019244,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 28,Homo sapiens,dead: yes,days to determined death status: 1243,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 57,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 28,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019244/suppl/GSM1019244_PA117_28A_101118_HG-U133_Plus_2_.CEL.gz,54675,not known,57,1243,not known,yes,female,adeno,0,not known,1a
GSM1019247,"Patient 36, male, adeno",GSM1019247,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 36,Homo sapiens,dead: yes,days to determined death status: 1123,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 1,age: 60,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 36,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019247/suppl/GSM1019247_PA117_36C_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,60,1123,not known,yes,male,adeno,1,not known,3a
GSM1019249,"Patient 41, female, adeno",GSM1019249,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 41,Homo sapiens,dead: no,days to determined death status: 2866,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 73,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 41,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019249/suppl/GSM1019249_PA117_41A_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,73,2866,not known,no,female,adeno,0,not known,1a
GSM1019253,"Patient 56, male, adeno",GSM1019253,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 56,Homo sapiens,dead: yes,days to determined death status: 857,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 64,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 56,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019253/suppl/GSM1019253_PA117_56A_101208_HG-U133_Plus_2_.CEL.gz,54675,not known,64,857,not known,yes,male,adeno,0,not known,1b
GSM1019254,"Patient 58, female, adeno",GSM1019254,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 58,Homo sapiens,dead: no,days to determined death status: 2761,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 56,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 58,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019254/suppl/GSM1019254_PA117_58A_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,56,2761,not known,no,female,adeno,1,not known,1a
GSM1019256,"Patient 62, female, adeno",GSM1019256,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 62,Homo sapiens,dead: yes,days to determined death status: 836,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 74,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 62,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019256/suppl/GSM1019256_PA117_62A_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,74,836,not known,yes,female,adeno,0,not known,1b
GSM1019257,"Patient 64, male, adeno",GSM1019257,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 64,Homo sapiens,dead: yes,days to determined death status: 1190,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 78,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 64,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019257/suppl/GSM1019257_PA117_64B_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,78,1190,not known,yes,male,adeno,1,not known,1a
GSM1019258,"Patient 66, male, adeno",GSM1019258,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 66,Homo sapiens,dead: yes,days to determined death status: 2170,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 58,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 66,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019258/suppl/GSM1019258_PA117_66A_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,58,2170,not known,yes,male,adeno,0,not known,1a
GSM1019259,"Patient 68, female, adeno",GSM1019259,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 68,Homo sapiens,dead: no,days to determined death status: 2589,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 54,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 68,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019259/suppl/GSM1019259_PA117_68A_101123_HG-U133_Plus_2_.CEL.gz,54675,not known,54,2589,not known,no,female,adeno,0,not known,3a
GSM1019260,"Patient 74, male, adeno",GSM1019260,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 74,Homo sapiens,dead: no,days to determined death status: 2350,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 49,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 74,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019260/suppl/GSM1019260_PA117_74A_101215_HG-U133_Plus_2_.CEL.gz,54675,not known,49,2350,not known,no,male,adeno,0,not known,1b
GSM1019261,"Patient 75, male, adeno",GSM1019261,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 75,Homo sapiens,dead: no,days to determined death status: 2308,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 53,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 75,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019261/suppl/GSM1019261_PA117_75A_101126_HG-U133_Plus_2_2.CEL.gz,54675,not known,53,2308,not known,no,male,adeno,0,not known,1a
GSM1019264,"Patient 79, female, adeno",GSM1019264,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 79,Homo sapiens,dead: yes,days to determined death status: 1205,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 0,age: 67,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 79,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019264/suppl/GSM1019264_PA117_79A_101126_HG-U133_Plus_2_.CEL.gz,54675,not known,67,1205,not known,yes,female,adeno,0,not known,3a
GSM1019265,"Patient 80, female, adeno",GSM1019265,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 80,Homo sapiens,dead: no,days to determined death status: 2316,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 51,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 80,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019265/suppl/GSM1019265_PA117_80A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,51,2316,not known,no,female,adeno,0,not known,1a
GSM1019268,"Patient 93, male, adeno",GSM1019268,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 93,Homo sapiens,dead: no,days to determined death status: 2448,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 53,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 93,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019268/suppl/GSM1019268_PA117_93A_101126_HG-U133_Plus_2_.CEL.gz,54675,not known,53,2448,not known,no,male,adeno,0,not known,1a
GSM1019270,"Patient 101, male, adeno",GSM1019270,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 101,Homo sapiens,dead: yes,days to determined death status: 1000,histology: adeno,tumor stage: 3a,performance status corresponding to who criteria: 1,age: 66,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 101,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019270/suppl/GSM1019270_PA117_101A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,66,1000,not known,yes,male,adeno,1,not known,3a
GSM1019272,"Patient 107, female, adeno",GSM1019272,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 107,Homo sapiens,dead: yes,days to determined death status: 1224,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 65,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 107,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019272/suppl/GSM1019272_PA117_107A_101215_HG-U133_Plus_2_.CEL.gz,54675,not known,65,1224,not known,yes,female,adeno,0,not known,1a
GSM1019273,"Patient 110, female, adeno",GSM1019273,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 110,Homo sapiens,dead: yes,days to determined death status: 1463,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 55,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 110,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019273/suppl/GSM1019273_PA117_110A_101126_HG-U133_Plus_2_.CEL.gz,54675,not known,55,1463,not known,yes,female,adeno,0,not known,1a
GSM1019274,"Patient 111, female, adeno",GSM1019274,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 111,Homo sapiens,dead: yes,days to determined death status: 50,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 2,age: 57,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 111,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019274/suppl/GSM1019274_PA117_111A_101215_HG-U133_Plus_2_.CEL.gz,54675,not known,57,50,not known,yes,female,adeno,2,not known,1a
GSM1019275,"Patient 114, female, adeno",GSM1019275,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 114,Homo sapiens,dead: yes,days to determined death status: 319,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 75,gender: female,adjuvant treatment: no,recurrence: yes,days to recurrence / to last visit: 162,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 114,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019275/suppl/GSM1019275_PA117_114A_101215_HG-U133_Plus_2_.CEL.gz,54675,no,75,319,162,yes,female,adeno,1,yes,1b
GSM1019283,"Patient 147, female, adeno",GSM1019283,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 147,Homo sapiens,dead: no,days to determined death status: 1928,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 68,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 147,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019283/suppl/GSM1019283_PA117_147A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,68,1928,not known,no,female,adeno,0,not known,1b
GSM1019285,"Patient 150, female, adeno",GSM1019285,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 150,Homo sapiens,dead: no,days to determined death status: 1826,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 47,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 150,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019285/suppl/GSM1019285_PA117_150A_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,47,1826,not known,no,female,adeno,0,not known,2b
GSM1019286,"Patient 154, male, adeno",GSM1019286,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 154,Homo sapiens,dead: yes,days to determined death status: 756,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 67,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 154,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019286/suppl/GSM1019286_PA117_154A_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,67,756,not known,yes,male,adeno,0,not known,1b
GSM1019288,"Patient 160, female, adeno",GSM1019288,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 160,Homo sapiens,dead: no,days to determined death status: 1859,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 60,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 160,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019288/suppl/GSM1019288_PA117_160A_101130_HG-U133_Plus_2_2.CEL.gz,54675,not known,60,1859,not known,no,female,adeno,0,not known,1b
GSM1019289,"Patient 163, male, adeno",GSM1019289,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 163,Homo sapiens,dead: yes,days to determined death status: 1011,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 78,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 163,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019289/suppl/GSM1019289_PA117_163A_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,78,1011,not known,yes,male,adeno,1,not known,1b
GSM1019290,"Patient 164, female, adeno",GSM1019290,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 164,Homo sapiens,dead: yes,days to determined death status: 1500,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 2,age: 79,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 164,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019290/suppl/GSM1019290_PA117_164A_101210_HG-U133_Plus_2_.CEL.gz,54675,not known,79,1500,not known,yes,female,adeno,2,not known,1b
GSM1019292,"Patient 173, male, adeno",GSM1019292,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 173,Homo sapiens,dead: yes,days to determined death status: 1181,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 67,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 173,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019292/suppl/GSM1019292_PA117_173B_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,67,1181,not known,yes,male,adeno,1,not known,1a
GSM1019295,"Patient 180, female, adeno",GSM1019295,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 180,Homo sapiens,dead: no,days to determined death status: 4760,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 2,age: 67,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 5052,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 180,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019295/suppl/GSM1019295_PA117_180A_101130_HG-U133_Plus_2_.CEL.gz,54675,no,67,4760,5052,no,female,adeno,2,no,1b
GSM1019298,"Patient 186, female, adeno",GSM1019298,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 186,Homo sapiens,dead: yes,days to determined death status: 1007,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 0,age: 57,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 186,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019298/suppl/GSM1019298_PA117_186B_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,57,1007,not known,yes,female,adeno,0,not known,2b
GSM1019299,"Patient 187, male, adeno",GSM1019299,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 187,Homo sapiens,dead: yes,days to determined death status: 1610,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 2,age: 51,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 187,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019299/suppl/GSM1019299_PA117_187A_101130_HG-U133_Plus_2_.CEL.gz,54675,not known,51,1610,not known,yes,male,adeno,2,not known,2b
GSM1019300,"Patient 190, male, adeno",GSM1019300,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 190,Homo sapiens,dead: yes,days to determined death status: 1367,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 73,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 190,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019300/suppl/GSM1019300_PA117_190B_101202_HG-U133_Plus_2_.CEL.gz,54675,not known,73,1367,not known,yes,male,adeno,1,not known,1b
GSM1019302,"Patient 209, female, adeno",GSM1019302,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 209,Homo sapiens,dead: no,days to determined death status: 4068,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 62,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 2369,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 209,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019302/suppl/GSM1019302_PA117_209A_101202_HG-U133_Plus_2_.CEL.gz,54675,no,62,4068,2369,no,female,adeno,0,no,1a
GSM1019303,"Patient 218, male, adeno",GSM1019303,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 218,Homo sapiens,dead: yes,days to determined death status: 766,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 52,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 218,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019303/suppl/GSM1019303_PA117_218A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,52,766,not known,yes,male,adeno,1,not known,1b
GSM1019305,"Patient 226, female, adeno",GSM1019305,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 226,Homo sapiens,dead: no,days to determined death status: 3846,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 67,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 4072,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 226,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019305/suppl/GSM1019305_PA117_226B_101202_HG-U133_Plus_2_.CEL.gz,54675,no,67,3846,4072,no,female,adeno,1,no,1a
GSM1019308,"Patient 241, male, adeno",GSM1019308,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 241,Homo sapiens,dead: yes,days to determined death status: 1221,histology: adeno,tumor stage: 2a,performance status corresponding to who criteria: 0,age: 71,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 241,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019308/suppl/GSM1019308_PA117_241B_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,71,1221,not known,yes,male,adeno,0,not known,2a
GSM1019309,"Patient 244, female, adeno",GSM1019309,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 244,Homo sapiens,dead: yes,days to determined death status: 979,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 83,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 244,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019309/suppl/GSM1019309_PA117_244A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,83,979,not known,yes,female,adeno,1,not known,1b
GSM1019310,"Patient 254, female, adeno",GSM1019310,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 254,Homo sapiens,dead: no,days to determined death status: 3217,histology: adeno,tumor stage: 4,performance status corresponding to who criteria: 0,age: 63,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 254,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019310/suppl/GSM1019310_PA117_254A_101203_HG-U133_Plus_2_.CEL.gz,54675,not known,63,3217,not known,no,female,adeno,0,not known,4
GSM1019311,"Patient 257, female, adeno",GSM1019311,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 257,Homo sapiens,dead: yes,days to determined death status: 1687,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 65,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 257,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019311/suppl/GSM1019311_PA117_257A_101208_HG-U133_Plus_2_.CEL.gz,54675,not known,65,1687,not known,yes,female,adeno,0,not known,1a
GSM1019312,"Patient 263, male, adeno",GSM1019312,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 263,Homo sapiens,dead: yes,days to determined death status: 2167,histology: adeno,tumor stage: 4,performance status corresponding to who criteria: 0,age: 72,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 263,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019312/suppl/GSM1019312_PA117_263A_101210_HG-U133_Plus_2_.CEL.gz,54675,not known,72,2167,not known,yes,male,adeno,0,not known,4
GSM1019313,"Patient 275, female, adeno",GSM1019313,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 275,Homo sapiens,dead: no,days to determined death status: 5063,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 3,age: 49,gender: female,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 5045,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 275,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019313/suppl/GSM1019313_PA117_275A_101210_HG-U133_Plus_2_.CEL.gz,54675,no,49,5063,5045,no,female,adeno,3,no,1a
GSM1019314,"Patient 276, male, adeno",GSM1019314,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 276,Homo sapiens,dead: no,days to determined death status: 4897,histology: adeno,tumor stage: 2a,performance status corresponding to who criteria: 0,age: 66,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 869,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 276,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019314/suppl/GSM1019314_PA117_276B_101208_HG-U133_Plus_2_.CEL.gz,54675,no,66,4897,869,no,male,adeno,0,no,2a
GSM1019316,"Patient 285, female, adeno",GSM1019316,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 285,Homo sapiens,dead: yes,days to determined death status: 1445,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 70,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 285,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019316/suppl/GSM1019316_PA117_285A_101210_HG-U133_Plus_2_.CEL.gz,54675,not known,70,1445,not known,yes,female,adeno,0,not known,1b
GSM1019318,"Patient 290, female, adeno",GSM1019318,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 290,Homo sapiens,dead: yes,days to determined death status: 2060,histology: adeno,tumor stage: 2b,performance status corresponding to who criteria: 1,age: 54,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 290,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019318/suppl/GSM1019318_PA117_290A_101210_HG-U133_Plus_2_.CEL.gz,54675,not known,54,2060,not known,yes,female,adeno,1,not known,2b
GSM1019320,"Patient 312, male, adeno",GSM1019320,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 312,Homo sapiens,dead: yes,days to determined death status: 1488,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 52,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 312,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019320/suppl/GSM1019320_PA117_312A_101202_HG-U133_Plus_2_.CEL.gz,54675,not known,52,1488,not known,yes,male,adeno,0,not known,1b
GSM1019321,"Patient 318, male, adeno",GSM1019321,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 318,Homo sapiens,dead: no,days to determined death status: 5207,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 0,age: 54,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 5423,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 318,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019321/suppl/GSM1019321_PA117_318B_101208_HG-U133_Plus_2_.CEL.gz,54675,no,54,5207,5423,no,male,adeno,0,no,1b
GSM1019324,"Patient 327, male, adeno",GSM1019324,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 327,Homo sapiens,dead: yes,days to determined death status: 2810,histology: adeno,tumor stage: 1b,performance status corresponding to who criteria: 1,age: 67,gender: male,adjuvant treatment: no,recurrence: no,days to recurrence / to last visit: 531,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 327,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019324/suppl/GSM1019324_PA117_327A_101210_HG-U133_Plus_2_.CEL.gz,54675,no,67,2810,531,yes,male,adeno,1,no,1b
GSM1019328,"Patient 348, male, adeno",GSM1019328,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 348,Homo sapiens,dead: yes,days to determined death status: 1113,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 1,age: 59,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 348,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019328/suppl/GSM1019328_PA117_348A_101208_HG-U133_Plus_2_.CEL.gz,54675,not known,59,1113,not known,yes,male,adeno,1,not known,1a
GSM1019330,"Patient 353, male, adeno",GSM1019330,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 353,Homo sapiens,dead: no,days to determined death status: 2515,histology: adeno,tumor stage: 1a,performance status corresponding to who criteria: 0,age: 53,gender: male,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 353,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019330/suppl/GSM1019330_PA117_353A_101208_HG-U133_Plus_2_.CEL.gz,54675,not known,53,2515,not known,no,male,adeno,0,not known,1a
GSM1019332,"Patient 360, female, adeno",GSM1019332,Public on Oct 12 2012,Oct 12 2012,Nov 30 2012,RNA,1,cancer cells from patient 360,Homo sapiens,dead: yes,days to determined death status: 1015,histology: adeno,tumor stage: 2a,performance status corresponding to who criteria: 1,age: 47,gender: female,adjuvant treatment: not known,recurrence: not known,days to recurrence / to last visit: not known,no treatment,no in vitro data,total RNA,"Five to ten sections (10µm) were cut from each frozen tissue block and collected into a tube with Buffer RLT (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Mini Kit following instructions from the manufacturer (Qiagen). RNA concentrations were measured with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, U.S.A.), and the quality (RNA Integrity Number, RIN) was assessed using the Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, U.S.A.).",biotin,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",9606,"For each sample, 2µg of total RNA from each sample was used to prepare biotinylated fragmented cRNA for analysis on Affymetrix Human Genome U133 plus 2 arrays (54675 probe sets, Affymetrix Inc., Santa Clara, U.S.A.). Sample preparation, processing and hybridization were performed according to the GeneChip® Expression Analysis Technical Manual (Affymetrix Inc., Rev. 5).",The arrays were washed and stained using a Fluidics Station 450 and finally scanned using a GeneChip® Scanner 3000 7G.,gene expression data from non small lung cancer frozen sample of patient 360,Biocondoctor affy package standard RMA preprocessing in Matrix Template,GPL570,"Patrick,,Micke",patrick.micke@igp.uu.se,Uppsala University,Rudbeck laboratory,Uppsala,75185,Sweden,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1019nnn/GSM1019332/suppl/GSM1019332_PA117_360A_101208_HG-U133_Plus_2_.CEL.gz,54675,not known,47,1015,not known,yes,female,adeno,1,not known,2a
